Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
China · Delayed Price · Currency is CNY 22.95
+1.27 (5.86%)
At close: Mar 6, 2026
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.58 billion as of March 6, 2026. Its market cap has increased by 27.12% in one year.
Market Cap
2.58B
Enterprise Value
3.20B
Revenue
831.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.95
Market Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.58B, a decrease of -49.28%. That is a compound annual growth rate of -12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.58B | 28.93% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 2.87B |
| Novoprotein Scientific | 2.83B |
| Shanghai Universal Biotech | 2.68B |
| Shandong Sito Bio-technology | 2.66B |
| Jilin Jian Yisheng Pharmaceutical | 2.64B |
| Shanghai Serum Bio-Technology | 2.53B |
| Jiangsu CoWin Biotech | 2.49B |
| Guiyang Xintian Pharmaceutical | 2.36B |